Skadden is representing Fresenius AG, a health care company in Germany, in its approximately US$5 billion acquisition of APP Pharmaceuticals, Inc., a provider of pharmaceutical products.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates